<<

© ECVAM DB-ALM: Method Summary

In vitro approaches for testing neurotoxicity through the GABAA receptor - Summary Neurotoxicity The effect of compounds (enhancement or inhibition) on GABA –mediated chloride flux may be predictive of their potential to produce inhibitory or excitatory transmission neurotoxicity through the GABAA receptor.

Objective & Application

TYPE OF TESTING : Part of a test battery, Screening LEVEL OF ASSESSMENT : Toxic potency, Toxic potential PURPOSE OF TESTING : Classification/labelling, Mechanistic studies, Ranking

The GABAA receptor is the molecular target of a wide type of compounds, including pesticides, industrial compounds and pharmaceuticals. Several in vitro approaches based on the determination of the function of the GABAA receptor are being developed for the screening of compounds that may produce neurotoxicity by impairing the physiological inhibitory neural transmission.

Basis of the Method

Gamma-aminobutyric acid (GABA) operates primarily as an inhibitory neurotransmitter in the mature brain and exerts a crucial role in regulating brain excitability. GABA mediates these processes by the activation of ionotropic (GABA A) and metabotropic (GABAB) receptors. The binding of GABA to its recognition site on the GABAA receptor leads to the opening of a channel permeable to chloride ions resulting, in most neurons, in an inhibitory signal. Blockage of the GABA-gated chloride channel by both competitive or non-competitive GABA antagonists leads to hyper-excitation of the central nervous system, convulsions and death, whereas excessive activation of the channel by GABA agonists or activators results in ataxia, paralysis and death.

The GABAA receptor is the molecular target of several organochlorine insecticides, compounds, the active component of absinthe a-, the anthelmintic avermectine, and the Amanita muscaria mushroom poison, . The GABAA receptor is also the molecular target of important classes of therapeutic drugs, such as , and anaesthetics. The different binding sites for GABA, benzodiazepines, barbiturates, anaesthetic steroids and the convulsant picrotoxinin are allosterically coupled. There are comprehensive updated reviews of the GABAA receptor (Kardos, 1999; Mehta and Ticku, 1999; Sieghart et al., 1999; Rudolph et al., 2001; Korpi et al., 2002).

In vitro testing of neurotoxicity through the GABAA receptor is performed by measuring ion flux by means of electrophysiological and transmembrane 36Cl- flux techniques and by radioreceptor binding assays by means of radioligand binding at the different recognition sites of the GABAA receptor. Guidances for neurotoxicity testing states that neurochemical endpoints are valuable where they are related to the mechanism of toxicity and where they are expected to have neurophysiological, neuropathological, or neurobehavioral correlates.(US EPA, 1998; OECD 2000).

Experimental Description Biological and Endpoint Measurement:

RECEPTOR BINDING: by measuring radioligand binding

GABAA RECEPTOR FUNCTION (Cl- FLUX): by means of transmembrane 36Cl- ion flux or electrophysiological measurements

Endpoint Value:

IC50

Experimental System:

Brain tissue preparations and primary cultured neurons from rat and mice, engineered cell lines and Xenopus oocytes expressing GABAA receptors

In vitroassays for determining Cl- flux through the GABAA receptor. Electrophysiological (patch-clamp) or radiotracer-based (36Cl- uptake) techniques are used to determine https://ecvam-dbalm.jrc.ec.europa.eu/methods-and-protocols/method-summaries page 1 / 8 © ECVAM DB-ALM: Method Summary

GABAA receptor function. Primary neuronal cultures, engineered cell lines and Xenopus oocytes expressing native or recombinant GABAA receptor subunits, are used in patch-clamp electrophysiology experiments (Nagata and Narahashi 1994, 1995; Nagata et al., 1994, 1996; Belelli et al., 1996; Aspinwall et al., 1997; Maskell et al., 2001). The assay determines the amplitude of the ionic current induced by GABA and the modifications (inhibition or enhancement) produced by the addition of the test agents. Intact primary cultured neurons and microsacs or synaptoneurosomes from brain tissue are used in the 36Cl- uptake assay (Obata et al., 1988; Bloomquist et al., 1986; Gant et al., 1987; Pomés et al., 1994a, b; Huang and Casida, 1996; Vale et al., 1999, 2003). The neuronal preparation is incubated with 36Cl- and GABA in the presence of test agents and 36Cl- uptake is measured by liquid scintillation counting.

In vitroradioreceptor binding assays at the GABAA receptor. Squires et al. (1983) first described the use of the radioligand [35S]-t-butyl bicyclophosphorothionate ([35S]TBPS) to label the picrotoxinin recognition site (also called the convulsant site) at the GABAA receptor in brain membranes. Membranes obtained from brain tissue or neuronal cultures as well as intact cultured neuronal cells are incubated with [35S]TBPS in the presence of test agents followed by the determination of bound radioactivity by using liquid scintillation counting (Squires et al., 1983, 1990; Llorens et al., 1990; Pomés et al., 1993; 1994a; Vale et al., 1997; Elster et al., 2000). The addition of competitive GABAA receptor antagonists to the binding assay allows to differentiate compounds that directly inhibit [35S]TBPS binding from those that allosterically inhibit [35S]TBPS binding (Squires et al., 1983, 1984; Vale et al., 1997). [3H]flunitrazepam binding to the recognition site at the GABAA receptor is performed in membranes obtained from brain tissue or cultured neurons as well as in intact cultured neuronal cells (Mehta and Ticku 1987, 1988, 1992; Squires et al., 1990; Harris et al., 1993; Vale et al., 1997; 1998; 1999; Elster et al., 2000; Ali and Olsen 2001; Fonfría et al., 2001). [3H]muscimol or [3H]GABA binding to the GABA recognition site at the GABAA receptor is performed in membranes obtained from brain tissue or cultured neurons (Horng and Wong 1979; Maksay 1988; Vale et al., 1997; Elster et al., 2000; Fonfría et al., 2001).

Data Analysis/Prediction Model

So far, no prediction model for neurotoxicity testing has been described yet. However, data found in the literature reveal that, in general, the relative potency of in inhibiting [ 35S]TBPS binding and GABA-stimulated chloride flux is in good agreement with their mammalian toxicity (Lawrence and Casida, 1984; Squires et al., 1984; Cole and Casida, 1986; Gant et al., 1987; Abalis et al., 1985; Bloomquist et al., 1986; Obata et al., 1988), establishing the toxicological relevance of this binding site for closely related compounds (Casida, 1993).

Test Compounds

All chemicals; agrochemicals.

Modifications

Patch clamp electrophysiology methods yield detailed information concerning mechanisms of action, but suffer with regard throughput screening. High throughput electrophysiology may be a reality in the future with the introduction of automated patch clamp instruments (Xu et al., 2001). Gross et al. (1997) and Egert et al. (1998, 2002) developed a method to assess neuronal activity in cultures grown on substrate-integrated microelectrode arrays: higher throughput but lower mechanistic specificity is obtained (Gramowski et al., 2000; Keefer et al., 2001; Potter et al., 2001). Fluorescent assays are being developed as alternative assays for measuring Cl- flux (Inglefield and Schwartz-Bloom, 1997; Chistina Grobin et al., 1999; Inglefield and Shafer, 2000; Kuner and Agustine, 2000; Adkins et al., 2001; Sah et al., 2002). At present, these assays are not fully developed and have not yet been used in neurotoxicity testing. Lawrence and Casida (1984) performed [35S]TBPS binding in the presence of a metabolic system. Compounds that undergo in vivo activation/detoxification showed enhanced/reduced potencies in the coupled in vitro TBPS assay. Tritiated radioligands have been developed for the analysis of the picrotoxinin site of the GABA-gated chloride channel (Huang and Casida, 1996, 1997; Rauh et al., 1997; Hamon et al., 1998). Among them, [3H]ethynylbicycloorthobenzoate ([3H]EBOB) has higher affinity and longer radioisotopic half-life than [ 35S]TBPS. https://ecvam-dbalm.jrc.ec.europa.eu/methods-and-protocols/method-summaries page 2 / 8 © ECVAM DB-ALM: Method Summary

Ozoe and Akamatsu (2001) reported 3D-QSAR analyses of non-competitive GABA antagonists by using [35S]TBPS binding data of about 50 compounds.

Two human neuronal differentiated cell lines (IMR-32 and NT2-N) that express different GABAA receptors subunits have been reported. Their pharmacology may depend on their degree of differentiation and heterogeneous expression of GABAA receptor isoforms (Anderson et al., 1993; Noble et al., 1993; Neelands et al., 1998, 1999; Sapp and Yeh, 2000).

Discussion

Measurements of GABA-induced Cl- flux and radioligand binding have demonstrated that the organochlorine pesticides and cyclodiene-related compounds block the GABAA receptor, in agreement with their convulsant properties (Bloomquist and Soderlund, 1985; Bloomquist et al., 1986; Cole and Casida, 1986; Llorens et al., 1990; Pomés et al., 1993, 1994a,b; Ogata et al., 1988, Nagata et al., 1994, 1996; Nagata and Narahashi 1994, 1995). Mutagenesis and pharmacophoric studies of the GABAA receptor support a mechanism of action in which these convulsants bind within the chloride channel lumen (Zhang et al., 1994; Jursky et al., 2000; Vale et al. 2003). Furthermore, there is a quantitative correlation between the potency to inhibit [35S]TBPS or [3H]EBOB binding and the potency to block GABA-stimulated chloride flux for a large variety of convulsant compounds (Gant et al., 1987; Bloomquist et al., 1986; Pomés et al., 1994b; Huang et al., 1996). Likewise, depressant compounds, including pharmaceuticals (benzodiazepines, barbiturates, anesthetics) and toxic agents, enhance GABA-stimulated chloride flux; in addition, some of them allosterically increase [3H]flunitrazepam binding in neuronal preparations (Mehta and Ticku, 1987,1992, Moody et al., 1993; Pomés et al., 1993, 1994b; Mihic et al., 1994; Belelli et al., 1996; Aspinwall et al., 1997; Vale et al., 1997; Maskell et al., 2001; Ratra et al., 2001)

GABAA receptors are composed of five subunits that can belong to eight different subunit classes. Subunit composition of GABAA receptors affects response to GABA agonists and modulators (Alsbo et al., 2001; Hansen et al., 2001; Korpi et al., 2002). In general, convulsants interacting at the picrotoxinin site show similar potency on inhibiting [35S]TBPS, [3H]EBOB binding or Cl- flux regardless of GABAA receptor subunities with the exception of the human b3 subunit (Nagata et al., 1994, 1996; Llorens et al., 1990; Aspinwall et al. 1997; Huang and Casida, 1997; Maskell et al., 2001; Ratra and Casida 2001; Ratra et al., 2001). However, specificity among compounds and mammal selective toxicity are better predicted by using the native GABAA receptor (Ratra et al., 2001). Contrarily, the allosteric effects of GABA mimetics on the picrotoxinin recognition site may depend on receptor subunit composition (Huang and Casida, 1997).

Advantages: Binding and electrophysiology assays provide data that are linked to the mechanism of action of the tested agents. Therefore, the data obtained are relevant for the prediction of toxicity. Binding assays are easy to be performed. Patch-clamp electrophysiologic techniques allow the measurement of any receptor and ion channel in practically any type of cells with a high degree of precision and time resolution. Determination of the GABAA receptor function in the presence of tested agents may identify convulsant and depressant compounds.

Limitations: Electrophysiology assays require high expertise and specific equipment. Performance of radiochemical assays requires that the laboratory have a radioactive installation. The 36Cl- uptake assay may not be suitable for screening purposes, due to the high radiation energy and long half-life of the radionuclide. The use of bioactivation systems has not been described so far. Only compounds that act on the GABAA receptor are identified.

Status

The herein described techniques still need significant basic research before they will be useful in tiered screening systems. Further development is needed to establish the adequate/s radioligand and fluorescent probes, as well as for the choice of the most adequate in vitro system(s) for the testing of neurotoxicity through the GABAA receptor.

Bibliography Abalis,I.M:; Eldefrawi,M.E.; Eldefrawi,A.T. (1985) https://ecvam-dbalm.jrc.ec.europa.eu/methods-and-protocols/method-summaries page 3 / 8 © ECVAM DB-ALM: Method Summary

High-affinity Stereospecific binding of cyclodiene insecticides and gamma-hexachlorocyclohezane to g-aminobutyric acis receptors of brain. Pesticide Biochemistry and Physiology 24, 95-102 Adkins,C.E.; Pillai,G.V.; Kerby,J.; Bonnert,T.P.; Haldon,C.; McKernan,R.M.; Gonzalez,J.E.; Oades,K.; Whiting,P.J.; Simpson,P.B. (2001) alpha4beta3delta GABA(A) receptors characterized by fluorescence resonance energy transfer-derived measurements of membrane potential. Journal of Biological Chemistry 276, 38934-38939 Ali,N.J.; Olsen,R.W. (2001) Chronic benzodiazepine treatment of cells expressing recombinant GABA(A) receptors uncouples allosteric binding: studies on possible mechanisms. Journal of Neurochemistry 79, 1100-1108 Alsbo,C.W.; Kristiansen,U.; Moller,F.; Hansen,S.L.; Johansen,F.F. (2001) GABAA receptor subunit interactions important for benzodiazepine and modulation: a patch-clamp and single cell RT-PCR study. European Journal of Neuroscience 13, 1673-1682 Anderson,S.M.; De Souza,R.J.; Cross,A.J. (1993) The human neuroblastoma cell line, IMR-32 possesses a GABAA receptor lacking the benzodiazepine modulatory site. Neuropharmacology 32, 455-460 Aspinwall,L.S.; Bermudez,I.; King,L.A.; Wafford,K.A. (1997) The interactions of hexachlorocyclohexane isomers with human gamma- aminobutyric acid(A) receptors expressed in Xenopus oocytes. Journal of Pharmacology and Experimental Therapeutics 282, 1557-1564 Belelli,D.; Callachan,H.; Hill-Venning,C.; Peters,J.A.; Lambert,J.J. (1996) Interaction of positive allosteric modulators with human and Drosophila recombinant GABA receptors expressed in Xenopus laevis oocytes. British Journal of Pharmacology 118, 563-576 Bloomquist,J.R.; Adams,P.M.; Soderlund,D.M. (1986) Inhibition of gamma-aminobutyric acid-stimulated chloride flux in mouse brain vesicles by polychlorocycloalkane and pyrethroid insecticides. Neurotoxicology 7(3), 11-20 Bloomquist,J.R.; Soderlund,D.M. (1985) Neurotoxic insecticides inhibit GABA-dependent chloride uptake by mouse brain vesicles. Biochemical and Biophysical Research Communications 133, 37-43 Casida,J.E. (1993) Insecticide action at the GABA-gated chloride channel: recognition, progress, and prospects. Archives of Insect Biochemistry and Physiology 22, 13-23 Chistina,Grobin A.; Inglefield,J.R.; Schwartz-Bloom,R.D.; Devaud,L.L.; Morrow,A.L. (1999) Fluorescence imaging of GABAA receptor-mediated intracellular [Cl-] in P19-N cells reveals unique pharmacological properties. Brain Research 872, 1-11 Cole,L.M.; Casida,J.E. (1986) Polychlorocycloalkane insecticide-induced convulsions in mice in relation to disruption of the GABA-regulated chloride ionophore. Life Sciences 39, 1855-1862 Egert U., Knott T., Schwarz C., Nawrot M., Brandt A., Rotter S. and Diesmann M. (2002) MEA-Tools: an open source toolbox for the analysis of multi-electrode data with MATLAB. Journal of Neuroscience Methods 117(1), 33-42 Egert U., Schlosshauer B., Fennrich S., Nisch W., Fejtl M., Knott T., Muller T. and Hammerle H. (1998) A novel organotypic long-term culture of the rat hippocampus on substrate-integrated multielectrode arrays. Brain Research. Brain Research Protocols 2(4), 229-242 Elster,L.; Schousboe,A.; Olsen,R.W. (2000) Stable GABA(A) receptor intermediates in SF-9 cells expressing alpha1, beta2 and gamma2 subunits. Journal of Neuroscience Research 61, 193-205 Fonfria,E.; Rodriguez-Farre,E.; Sunol,C. (2001) https://ecvam-dbalm.jrc.ec.europa.eu/methods-and-protocols/method-summaries page 4 / 8 © ECVAM DB-ALM: Method Summary

Fonfria,E.; Rodriguez-Farre,E.; Sunol,C. (2001) Mercury interaction with the GABA(A) receptor modulates the benzodiazepine binding site in primary cultures of mouse cerebellar granule cells. Neuropharmacology 41, 819-833 Gant,D.B.; Eldefrawi,M.E.; Eldefrawi,A.T. (1987) Cyclodiene insecticides inhibit GABAA receptor-regulated chloride transport. Toxicology and Applied Pharmacology 88, 313-321 Gramowski A., Schiffmann D. and Gross G.W. (2000) Quantification of acute neurotoxic effects of trimethyltin using neuronal networks cultured on microelectrode arrays. Neurotoxicology 21(3), 331-342 Gross G.W., Harsch A., Rhoades B.K. and Gopel W. (1997) Odor, drug and toxin analysis with neuronal networks in vitro: extracellular array recording of network responses. Biosensors & Bioelectronics 12(5), 373-393 Hamon,A.; Le Corronc,H.; Hue,B.; Rauh,J.J.; Sattelle,D.B. (1998) BIDN, a bicyclic dinitrile convulsant, selectively blocks GABA-gated Cl- channels. Brain Research 780, 20-26 Hansen S.L; Ebert B.; Fjalland B.; Kristiansen U. (2001) Effects of GABAA receptor partial agonists inprimary cultures of cerebellar granulle neurons and cerebral cortical neurons reflect different receptor subunit compositions. British Journal of Pharmacology 133, 539-549 Harris,B.; Wong,G.; Skolnick,P. (1993) Neurochemical actions of inhalational anesthetics at the GABAA receptor complex. Journal of Pharmacology and Experimental Therapeutics 265, 1392-1398 Horng,J.S.; Wong,D.T. (1979) gamma-Aminobutyric acid receptors in cerebellar membranes of rat brain after a treatment with Triton X-100. Journal of Neurochemistry 32, 1379-1386 Huang J. and Casida J.E. (1996) Characterization of [3H]ethynylbicycloorthobenzoate ([3H]EBOB) binding and the action of insecticides on the gamma-aminobutyric acid-gated chloride channel in cultured cerebellar granule neurons. Journal of Pharmacology and Experimental Therapeutics 279, 1191-1196 Huang,J.; Casida,J.E. (1997) Role of cerebellar granule cell-specific GABAA receptor subtype in the differential sensitivity of [3H]ethynylbicycloorthobenzoate binding to GABA mimetics. Neuroscience Letters 225, 85-88 Inglefield,J.R.; Schwartz-Bloom,R.D. (1997) Confocal imaging of intracellular chloride in living brain slices: measurement of GABAA receptor activity. Journal of Neuroscience Methods 75, 127-135 Inglefield,J.R.; Shafer,T.J. (2000) Perturbation by the PCB mixture aroclor 1254 of GABA(A) receptor- mediated calcium and chloride responses during maturation in vitro of rat neocortical cells. Toxicology and Applied Pharmacology 164, 184-195 Jursky,F.; Fuchs,K.; Buhr,A.; Tretter,V.; Sigel,E.; Sieghart,W. (2000) Identification of amino acid residues of GABA(A) receptor subunits contributing to the formation and affinity of the tert- butylbicyclophosphorothionate binding site. Journal of Neurochemistry 74, 1310-1316 Kardos,J. (1999) Recent advances in GABA research. Neurochemistry International 34, 353-358 Keefer E.W., Norton S.J., Boyle N.A., Talesa V. and Gross G.W. (2001) Acute toxicity screening of novel AChE inhibitors using neuronal networks on microelectrode arrays. Neurotoxicology 22(1), 3-12 Korpi,E.R.; Grunder,G.; Luddens,H. (2002) https://ecvam-dbalm.jrc.ec.europa.eu/methods-and-protocols/method-summaries page 5 / 8 © ECVAM DB-ALM: Method Summary

Korpi,E.R.; Grunder,G.; Luddens,H. (2002) Drug interactions at GABA(A) receptors. Progress in Neurobiology 67, 113-159 Kuner,T.; Augustine,G.J. (2000) A genetically encoded ratiometric indicator for chloride: capturing chloride transients in cultured hippocampal neurons. Neuron 27, 447-459 Lawrence,L.J.; Casida,J.E. (1984) Interactions of lindane, toxaphene and cyclodienes with brain-specific t-butylbicyclophosphorothionate receptor. Life Sciences 35, 171-178 Llorens,J.; Sunol,C.; Tusell,J.M.; Rodriguez-Farre,E. (1990) Lindane inhibition of [35S]TBPS binding to the GABAA receptor in rat brain. Neurotoxicology and Teratology 12, 607-610 Maksay,G. (1988) GABAA receptor populations bind agonists and antagonists differentially and with opposite affinities. Journal of Neurochemistry 50, 1865-1871 Maskell,P.D.; Wafford,K.A.; Bermudez,I. (2001) Effects of gamma-HCH and delta-HCH on human recombinant GABA(A) receptors: dependence on GABA(A) receptor subunit combination. British Journal of Pharmacology 132, 205-212 Mehta,A.K.; Ticku,M.K. (1999) An update on GABAA receptors. Brain Research. Brain Research Reviews 29, 196-217 Mehta,A.K.; Ticku,M.K. (1992) Chronic GABA exposure down-regulates GABA-benzodiazepine receptor- ionophore complex in cultured cerebral cortical neurons. Brain Research. Molecular Brain Research 16, 29-36 Mehta,A.K.; Ticku,M.K. (1988) Developmental aspects of benzodiazepine receptors and GABA-gated chloride channels in primary cultures of spinal cord neurons. Brain Research 545, 156-163 Mehta,A.K.; Ticku,M.K. (1987) Characteristics of flunitrazepam binding to intact primary cultured spinal cord neurons and its modulation by GABAergic drugs. Journal of Neurochemistry 49, 1491-1497 Mihic,S.J.; McQuilkin,S.J.; Eger,E.I.; Ionescu,P.; Harris,R.A. (1994) Potentiation of gamma-aminobutyric acid type A receptor-mediated chloride currents by novel halogenated compounds correlates with their abilities to induce general anesthesia. Molecular Pharmacology 46, 851-857 Moody,E.J.; Harris,B.D.; Skolnick,P. (1993) Stereospecific actions of the inhalation anesthetic isoflurane at the GABAA receptor complex. Brain Research 615, 101-106 Nagata,K.; Hamilton,B.J.; Carter,D.B.; Narahashi,T. (1994) Selective effects of on the GABAA receptor-channel subunits expressed in human embryonic kidney cells. Brain Research 645, 19-26 Nagata,K.; Huang,C.S.; Hamilton,B.J.; Carter,D.B.; Narahashi,T. (1996) Differential effects of hexachlorocyclohexane isomers on the GABA receptor subunits expressed in human embryonic kidney cell line. Brain Research 738, 131-137 Nagata,K.; Narahashi,T. (1995) Differential effects of hexachlorocyclohexane isomers on the GABA receptor-chloride channel complex in rat dorsal root ganglion neurons. Brain Research 704, 85-91 Nagata,K.; Narahashi,T. (1994) Dual action of the cyclodiene insecticide dieldrin on the gamma- aminobutyric acid receptor-chloride https://ecvam-dbalm.jrc.ec.europa.eu/methods-and-protocols/method-summaries page 6 / 8 © ECVAM DB-ALM: Method Summary

Dual action of the cyclodiene insecticide dieldrin on the gamma- aminobutyric acid receptor-chloride channel complex of rat dorsal root ganglion neurons. Journal of Pharmacology and Experimental Therapeutics 269, 164-171 Neelands,T.R.; Greenfield,L.J.,Jr.; Zhang,J.; Turner,R.S.; Macdonald,R.L. (1998) GABAA receptor pharmacology and subtype mRNA expression in human neuronal NT2-N cells. Journal of Neuroscience 18, 4993-5007 Neelands,T.R.; Zhang,J.; Macdonald,R.L. (1999) GABA(A) receptors expressed in undifferentiated human teratocarcinoma NT2 cells differ from those expressed by differentiated NT2-N cells. Journal of Neuroscience 19, 7057-7065 Noble,P.J.; Anderson,S.M.; De Souza,R.J.; Cross,A.J.; Stephenson,F.A. (1993) Identification of the GABAA receptor alpha 3 subunit in the IMR-32 neuroblastoma cell line. Journal of Neurochemistry 61, 752-755 OECD (2000) Revised Draft Guidance Document for Neurotoxicity Testing (Series on Testing and Assessment Nº 20). OECD Environmental Health and Safety Division Obata,T.; Yamamura,H.I.; Malatynska,E.; Ikeda,M.; Laird,H.; Palmer,C.J.; Casida,J.E. (1988) Modulation of gamma-aminobutyric acid-stimulated chloride influx by bicycloorthocarboxylates, bicyclophosphorus esters, polychlorocycloalkanes and other cage convulsants. Journal of Pharmacology and Experimental Therapeutics 244, 802-806 Ogata,N.; Vogel,S.M.; Narahashi,T. (1988) Lindane but not deltamethrin blocks a component of GABA-activated chloride channels. FASEB Journal 2, 2895-2900 Ozoe,Y.; Akamatsu,M. (2001) Non-competitive GABA antagonists: probing the mechanisms of their selectivity for insect versus mammalian receptors. Pest Management Science 57, 923-931 Pancrazio,J.J.; Keefer,E.W.; Ma,W.; Stenger,D.A.; Gross,G.W. (2001) Neurophysiologic effects of chemical agent hydrolysis products on cortical neurons in vitro. Neurotoxicology 22, 393-400 Pomes,A.; Frandsen,A.; Sunol,C.; Sanfeliu,C.; Rodriguez-Farre,E.; Schousboe,A. (1994) Lindane cytotoxicity in cultured neocortical neurons is ameliorated by GABA and flunitrazepam. Journal of Neuroscience Research 39, 663-668 Pomes,A.; Rodriguez-Farre,E.; Sunol,C. (1994) Disruption of GABA-dependent chloride flux by cyclodienes and hexachlorocyclohexanes in primary cultures of cortical neurons. Journal of Pharmacology and Experimental Therapeutics 271, 1616-1623 Pomes,A.; Rodriguez-Farre,E.; Sunol,C. (1993) Inhibition of t-[35S]butylbicyclophosphorothionate binding by convulsant agents in primary cultures of cerebellar neurons. Brain Research. Developmental Brain Research 73, 85-90 Potter,S.M. and DeMarse,T.B. (2001) A new approach to neural cell culture for long-term studies. Journal of Neuroscience Methods 110 (1-2), 17-24 Ratra,G.S.; Casida,J.E. (2001) GABA receptor subunit composition relative to insecticide potency and selectivity. Toxicology Letters 112, 215-222 Ratra,G.S.; Kamita,S.G.; Casida,J.E. (2001) Role of human GABA(A) receptor beta3 subunit in insecticide toxicity. Toxicology and Applied Pharmacology 172, 233-240 Rauh,J.J.; Benner,E.; Schnee,M.E.; Cordova,D.; Holyoke,C.W.; Howard,M.H.; Bai,D.; Buckingham,S.D.; Hutton,M.L.; Hamon,A.; Roush,R.T.; Sattelle,D.B. (1997) Effects of [3H]-BIDN, a novel bicyclic dinitrile radioligand for GABA- gated chloride channels of insects and vertebrates. British Journal of Pharmacology 121, 1496-1505 Rudolph,U.; Crestani,F.; Mohler,H. (2001) https://ecvam-dbalm.jrc.ec.europa.eu/methods-and-protocols/method-summaries page 7 / 8 © ECVAM DB-ALM: Method Summary

GABA(A) receptor subtypes: dissecting their pharmacological functions. Trends in Pharmacological Sciences 22, 188-194 Sah,R.; Galeffi,F.; Ahrens,R.; Jordan,G.; Schwartz-Bloom,R.D. (2002) Modulation of the GABA(A)-gated chloride channel by reactive oxygen species. Journal of Neurochemistry 80, 383-391 Sapp,D.W.; Yeh,H.H. (2000) Heterogeneity of GABA(A) receptor-mediated responses in the human IMR- 32 neuroblastoma cell line. Journal of Neuroscience Research 60, 504-510 Sieghart,W.; Fuchs,K.; Tretter,V.; Ebert,V.; Jechlinger,M.; Hoger,H.; Adamiker,D. (1999) Structure and subunit composition of GABA(A) receptors. Neurochemistry International 34, 379-385 Squires,R.F.; Casida,J.E.; Richardson,M.; Saederup,E. (1983) [35S]t-butylbicyclophosphorothionate binds with high affinity to brain- specific sites coupled to gamma-aminobutyric acid-A and ion recognition sites. Molecular Pharmacology 23, 326-336 Squires,R.F.; Saederup,E.; Crawley,J.N.; Skolnick,P.; Paul,S.M. (1984) Convulsant potencies of tetrazoles are highly correlated with actions on GABA/benzodiazepine/ receptor complexes in brain. Life Sciences 35, 1439-1444 Squires,R.F.; Saederup,E.; Damgaard,I.; Schousboe,A. (1990) Development of benzodiazepine and picrotoxin (t- butylbicyclophosphorothionate) binding sites in rat cerebellar granule cells in culture. Journal of Neurochemistry 54, 743-478 US EPA (1998) Guidelines for Neurotoxicity Risk Assessment (EPA/630/R-95/001F). Federal Register and United States Environmental Protection Agency (US EPA); http://www.epa.gov/nceawww1/raf/pdfs/neurotox.pdf ; (Feb. 18, 2004) 63(93), 26926-26954 Vale C., Fonfria E., Bujons J., Messeguer A., Rodriguez-Farre E. and Sunol C. (2003) The organochlorine pesticides g-hexachlorocyclohexane (lindane), a- and dieldrin differentially interact with gabaa and glycine-gated chloride channels in primary cultures of cerebellar granule cells. Neuroscience 117, 397-403 Vale C., Pomes A., Rodriguez-Farre E. and Sunol C. (1997) Allosteric interactions between gamma-aminobutyric acid, benzodiazepine and picrotoxinin binding sites in primary cultures of cerebellar granule cells. Differential effects induced by gamma- and delta- hexachlorocyclohexane. European Journal of Pharmacology 319, 343-353 Vale,C.; Damgaard,I.; Sunol,C.; Rodriguez-Farre,E.; Schousboe,A. (1998) Cytotoxic action of lindane in neocortical GABAergic neurons is primarily mediated by interaction with flunitrazepam-sensitive GABA(A) receptors. Journal of Neuroscience Research 52, 276-285 Vale,C.; Vilaro,M.T.; Rodriguez-Farre,E.; Sunol,C. (1999) Effects of the conformationally restricted GABA analogues, cis- and trans-4-aminocrotonic acid, on GABA neurotransmission in primary neuronal cultures. Journal of Neuroscience Research 57, 95-105 Xu J., Wang X., Ensign B., Li M., Wu L., Guia A. and Xu J. (2001) Ion-channel assay technologies: quo vadis?. Drug Discovery Today 6(24), 1278-1287 Zhang,H.G.; ffrench-Constant,R.H.; Jackson,M.B. (1994) A unique amino acid of the Drosophila GABA receptor with influence on drug sensitivity by two mechanisms. Journal of Physiology 479(Pt 1), 65-75

Last update: January 2003

https://ecvam-dbalm.jrc.ec.europa.eu/methods-and-protocols/method-summaries page 8 / 8